1![ORIGINAL ARTICLE Clinical Implications of Molecular PEGylation on Therapeutic Proteins Nandhakumar Sathyamoorthy, Dhanaraju Dasaratha Magharla Department of Pharmaceutics, GIET School of Pharmacy, Rajahmundry, Andhra Pr ORIGINAL ARTICLE Clinical Implications of Molecular PEGylation on Therapeutic Proteins Nandhakumar Sathyamoorthy, Dhanaraju Dasaratha Magharla Department of Pharmaceutics, GIET School of Pharmacy, Rajahmundry, Andhra Pr](https://www.pdfsearch.io/img/2795ca5548d2273e5167c6969d6d15d9.jpg) | Add to Reading ListSource URL: www.jbclinpharm.orgLanguage: English - Date: 2017-04-19 09:37:06
|
---|
2![Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1
Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1 Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1
Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1](https://www.pdfsearch.io/img/d9466687cc81d4da30b8ad8af3dd4692.jpg) | Add to Reading ListSource URL: www.mvpharm.comLanguage: English - Date: 2016-07-11 16:55:08
|
---|
3![Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1
Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1 Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1
Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1](https://www.pdfsearch.io/img/a31f260883650982cd3fe760af3af5f7.jpg) | Add to Reading ListSource URL: www.mvpharm.comLanguage: English - Date: 2016-07-11 16:49:52
|
---|
4![Microsoft Word - Savient Press Release ACRdoc Microsoft Word - Savient Press Release ACRdoc](https://www.pdfsearch.io/img/52437b6904432bd8669fb50b9f73721f.jpg) | Add to Reading ListSource URL: www.mvpharm.comLanguage: English - Date: 2016-07-11 16:59:27
|
---|
5![Microsoft Word - Savient Phase 3 Dosing press releasedoc Microsoft Word - Savient Phase 3 Dosing press releasedoc](https://www.pdfsearch.io/img/66de2c445374b0f00445895763cd8730.jpg) | Add to Reading ListSource URL: www.mvpharm.comLanguage: English - Date: 2016-07-11 16:59:22
|
---|
6![Molecular Immunology–246 Contents lists available at ScienceDirect Molecular Immunology journal homepage: www.elsevier.com/locate/molimm Molecular Immunology–246 Contents lists available at ScienceDirect Molecular Immunology journal homepage: www.elsevier.com/locate/molimm](https://www.pdfsearch.io/img/81048c0386da49fb19c76368605e64de.jpg) | Add to Reading ListSource URL: www.mvpharm.comLanguage: English - Date: 2016-07-11 16:59:01
|
---|
7![Microsoft Word - Savient press release Puricase SPAdoc Microsoft Word - Savient press release Puricase SPAdoc](https://www.pdfsearch.io/img/b241bfcb5dc69f183c1671238e0af607.jpg) | Add to Reading ListSource URL: www.mvpharm.comLanguage: English - Date: 2016-07-11 17:00:21
|
---|
8![Amended Safety Assessment of PEGylated Oils as Used in Cosmetics Status: Release Date: Panel Meeting Date: Amended Safety Assessment of PEGylated Oils as Used in Cosmetics Status: Release Date: Panel Meeting Date:](https://www.pdfsearch.io/img/936b9e7d28f6aaebb6a688b5e3e2747b.jpg) | Add to Reading ListSource URL: www.cir-safety.orgLanguage: English - Date: 2015-12-21 17:21:32
|
---|
9![Microsoft Word - Savient Reports Positive Top-Line Resultsdoc Microsoft Word - Savient Reports Positive Top-Line Resultsdoc](https://www.pdfsearch.io/img/b6a21b0cfbedfd8388752f5277bc6a63.jpg) | Add to Reading ListSource URL: www.mvpharm.comLanguage: English - Date: 2016-07-11 16:59:55
|
---|
10![Microsoft Word - Savient Resubmits Biologics License Application for KRYSTEXXAdoc Microsoft Word - Savient Resubmits Biologics License Application for KRYSTEXXAdoc](https://www.pdfsearch.io/img/74d8de2ad09205e26558b5d0d23b2ea3.jpg) | Add to Reading ListSource URL: www.mvpharm.comLanguage: English - Date: 2016-07-11 16:59:56
|
---|